Skip to main content
SpringerLink
Log in

Inhibition of proliferation of T47D human breast cancer cells: Alterations in progesterone receptor and p53 tumor suppressor protein

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

We have investigated the influence of three structurally different but functionally related compounds [1, 10 ortho-phenanthroline (phenanthroline), Rifampicin and aurin tricarboxylic acid (ATA)] on the rate and the extent of proliferation of progesterone-responsive T47D human breast cancer cells. These compounds have previously been used in this laboratory and have been shown to modulate properties of nucleic acid binding proteins. Because p53 and the progesterone receptor (PR) are both DNA binding proteins that appear to regulate proliferation of breast cells, alterations in T47D cell p53 and PR levels were examined to determine their relevance in cell proliferation. T47D cells were grown in the absence of phenol red and in the presence of 5% fetal calf serum with or without charcoal stripping in the presence of the inhibitors. The rate of proliferation of cells grown in Rifampicin containing medium exhibited nearly 70% inhibition. Phenanthroline, a known metal chelator, was an effect ive inhibitor of proliferation at 3 mM reducing the cell number by more than 75%. ATA (0.24–2.4 µg/ml) inhibited the growth of the cells by nearly 50%. Analysis of the mechanism of action of these compounds revealed that treatment with these compounds caused specific changes in the molecular composition of T47D cell PR. Whereas ATA caused increased stability of PR isoforms, Rifampicin induced a upshift in the mobility of PR in SDS gels – a phenomenon associated with hyperphosphorylation of steroid receptors (SRs). Phenanthroline treatment (> 2 mM) caused a complete down-regulation of PR and the tumor suppressor protein, p53. The downregulation of p53 paralleled the changes in the molecular composition of PR. We propose that the inhibition of T47D cell proliferation by phenanthroline, Rifampicin and ATA results from a number of cellular changes that include regulation of p53 and PR. (Mol Cell Biochem 175: 81–89, 1997)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Clarke CL, Sutherland RL: Progestin regulation of cellular proliferation. Endocrine Rev 11: 266–301, 1990

    Google Scholar 

  2. Horwitz KB: The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocrine Rev 13: 146–163, 1992

    Google Scholar 

  3. Horwitz KB: The antiprogestin RU38486: Receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells. Endocrinology 116: 2236–2245, 1985

    Google Scholar 

  4. Takimoto GS, Tasset DM, Eppert AC, Horwitz KB: Hormone-induced progesterone receptor phosphorylation consists of sequential DNA dependent DNA-dependent stages: Analysis with zinc finger mutants and the progesterone antagonist ZK98299. Proc Natl Acad Sci USA 89: 3050–3054, 1992

    Google Scholar 

  5. Sheridan PL, Evans RM, Horwitz KB: Phorphotryptic peptide analysis of human progesterone receptors. New phosphorylated sites formed in nuclei after hormone treatment. J Biol Chem 264: 6250–6258, 1989

    Google Scholar 

  6. Sartorius CA, Melville MY, Hovland AR, Tung L, Takimoto GS, Horwitz KB: A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol 8: 1347–1360, 1994

    Google Scholar 

  7. Moudgil VK, Weekes GA: Inhibition of hen oviduct estradiol receptor by aurintricarboxylic acid. FEBS Lett 94: 324–326, 1978

    Google Scholar 

  8. Moudgil VK, Eessalu TE: Sensitivity of progesterone receptor to aurintricarboxylic acid: Inhibition of nuclear uptake, ATP and DNA binding. Biochim Biophys Acta 627: 301–312, 1980

    Google Scholar 

  9. Moudgil VK, Eessalu TE: Inhibition of nuclear uptake and ATPSepharose binding of progesterone-receptor complex by aurintricarboxylic acid. Arch Biochem Biophys 213: 98–108, 1982

    Google Scholar 

  10. Moudgil VK Caradonna VM: Inhibition of nuclear uptake of glucocorticoid receptor complex by aurintricarboxylic acid. J Steroid Biochem 17: 585–589, 1982

    Google Scholar 

  11. Moudgil VK, Cikalo M, Samokyszyn VM, Eessalu TE, Singh VB: Interaction of chick oviduct progesterone receptor with immobilized aurintricarboxylic acid. J Steroid Biochem 22: 747–751, 1985

    Google Scholar 

  12. Moudgil VK, Caradonna VM: Modulation of DNA binding of glucocorticoid receptor complex by aurintricarboxylic acid. J Steroid Biochem 23: 125–132, 1985

    Google Scholar 

  13. Shyamala G: Is the estrogen receptor of mammary glands a metalloprotein? Biochem Biophys Res Commun 64: 408–415, 1975

    Google Scholar 

  14. Lohmar PH, Toft DO: Inhibition of the binding of progesterone receptor to nuclei. Effects of o-phenanthroline and rifamycin AF/103. Biochem Biophys Res Commun 67: 8–15, 1975

    Google Scholar 

  15. Chang CH, Yarbo JW: Comparative effects of 1, 10-phenanthroline and 1, 7-phenanthroline on DNA and RNA synthesis in mouse spleen. Life Sci 22: 1007–1010, 1978

    Google Scholar 

  16. Meilhac M, Tysper Z, Chambon P: Animal DNA-dependent RNA polymerase. Eur J Biochem 28: 291–300, 1972

    Google Scholar 

  17. Tsai M-J, Saunders G: Action of rifamycin derivatives on RNA polymerase of human leukemic lymphocytes. Proc Natl Acad Sci USA 70: 2072–2076, 1973

    Google Scholar 

  18. Grollman AP, Stewart ML: Inhibition of the attachment of mRNA to ribosomes. Proc Natl Acad Sci USA 61: 719–725, 1968

    Google Scholar 

  19. Oren M: p53: the ultimate tumor suppressor gene? FASEB J 6: 3169–3176, 1992

    Google Scholar 

  20. Hurd C, Khattree N, Alban P, Nag K, Jhanwar SC, Dinda S, Moudgil VK: Hormonal regulation of the p53 tumor suppressor protein in T47D human breast cancer carcinoma cell line. J Biol Chem 270: 28507–28510, 1995

    Google Scholar 

  21. Estes PA, Suba EJ, Lawlwer-Heavner J, El-Ashry D, Wei LL, Toft DO, Sullivan WP, Horwitz KB, Edwards DP: Immunologic analysis of human breast cancer progesterone receptors. 1. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies. Biochemistry 26: 6250–6262, 1987

    Google Scholar 

  22. Butler WB: Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle. Anal Biochem 141: 70–73, 1984

    Google Scholar 

  23. Kodali S, Burkley M, Nag K, Taylor RC, Moudgil VK: Taxol and cisplatin inhibit proliferation of T47D human breast cancer cell. Biochem Biophys Res Commun 202: 1413–1419, 1994

    Google Scholar 

  24. Tsutsui K, Yamaguchi M, Oda T: Aurintricarboxylic acid as a probe for the analysis of chromatin structure. Biochem Biophys Res Commun 55: 493–500, 1977

    Google Scholar 

  25. Blumenthal T, Landers TA: The inhibition of nucleic acid binding proteins by aurintricarboxylic acid. Biochem Biophys Res Commun 55: 680–688, 1973

    Google Scholar 

  26. Givens JF, Manly KF: Inhibition of RNA-directed DNA polymerase by aurintricarboxylic acid. Nucleic Acid Res 3: 405–418, 1976

    Google Scholar 

  27. Cushman M, Wang P, Chang SH, Wild C, Clercq ED, Schols D, Goldman ME, Bowen JA: Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogos: Direct correlation of antiviral potency with molecular weight. J Med Chem 34: 329–337, 1991

    Google Scholar 

  28. Schwartzman RA, Cidlowski JA: Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocrin Rev 14: 133–151, 1993

    Google Scholar 

  29. Thompson EB: Apoptosis and steroid hormones. Mol Endocrinol 8: 665–673, 1994

    Google Scholar 

  30. Hughes FM Jr, Cidlowski JA: Regulation of apoptosis in S49 cells. J Steroid Biochem Mol Biol 49: 303–310, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biological Sciences and the Institute for Biochemistry and Biotechnology, Oakland University, Rochester, Michigan, USA

    Sumi Dinda, Sandhya Kodali-Gali, Lisa Sevilla, Michael Burkley, Cliff Hurd & V.K. Moudgil

Authors
  1. Sumi Dinda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandhya Kodali-Gali
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lisa Sevilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Burkley
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cliff Hurd
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V.K. Moudgil
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dinda, S., Kodali-Gali, S., Sevilla, L. et al. Inhibition of proliferation of T47D human breast cancer cells: Alterations in progesterone receptor and p53 tumor suppressor protein. Mol Cell Biochem 175, 81–89 (1997). https://doi.org/10.1023/A:1006841413053

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006841413053

Search

Navigation